Alembic Pharmaceuticals (India) Price on June 18, 2024
| APLLTD Stock | 1,081 7.20 0.66% |
Below is the normalized historical share price chart for Alembic Pharmaceuticals Limited extending back to September 20, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Alembic Pharmaceuticals stands at 1,081, as last reported on the 29th of November, with the highest price reaching 1,094 and the lowest price hitting 1,062 during the day.
If you're considering investing in Alembic Stock, it is important to understand the factors that can impact its price. At this point, Alembic Pharmaceuticals is very steady. Alembic Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0188, which signifies that the company had a 0.0188% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Alembic Pharmaceuticals Limited, which you can use to evaluate the volatility of the firm. Please confirm Alembic Pharmaceuticals' risk adjusted performance of 0.0213, and Mean Deviation of 1.8 to double-check if the risk estimate we provide is consistent with the expected return of 0.0475%.
As of November 29, 2024, Total Stockholder Equity is expected to decline to about 26.7 B. In addition to that, Common Stock Shares Outstanding is expected to decline to about 209.7 M. Alembic Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1 K | 50 Day MA 1.1 K | Beta 0.691 |
Alembic |
Sharpe Ratio = 0.0188
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | APLLTD |
Estimated Market Risk
| 2.53 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Alembic Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alembic Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 4.3758 | Enterprise Value Ebitda 21.4238 | Price Sales 3.3432 | Shares Float 58.3 M | Wall Street Target Price 1.1 K |
Alembic Pharmaceuticals Valuation on June 18, 2024
It is possible to determine the worth of Alembic Pharmaceuticals on a given historical date. On June 18, 2024 Alembic was worth 899.75 at the beginning of the trading date compared to the closed value of 858.32. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Alembic Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Alembic Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alembic Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Alembic Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 877.51 | 899.85 | 874.84 | 878.30 | 154,091 | |
06/18/2024 | 899.75 | 904.80 | 854.76 | 858.32 | 689,684 |
| 872.46 | 884.97 | 849.42 | 852.88 | 300,739 |
| Backtest Alembic Pharmaceuticals | | | Alembic Pharmaceuticals History | | | Alembic Pharmaceuticals Valuation | Previous | Next |
Alembic Pharmaceuticals Trading Date Momentum on June 18, 2024
| On June 19 2024 Alembic Pharmaceuticals Limited was traded for 852.88 at the closing time. The highest price during the trading period was 884.97 and the lowest recorded bid was listed for 849.42 . The volume for the day was 300.7 K. This history from June 19, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 0.63% . The overall trading delta to the current price is 1.38% . |
Alembic Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Alembic Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Alembic Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Alembic financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Alembic Pharmaceuticals Stock history
Alembic Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alembic is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alembic Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alembic Pharmaceuticals stock prices may prove useful in developing a viable investing in Alembic Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 226 M | 209.7 M | |
| Net Income Applicable To Common Shares | 3.9 B | 6.1 B |
Alembic Pharmaceuticals Quarterly Net Working Capital |
|
Alembic Pharmaceuticals Stock Technical Analysis
Alembic Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Alembic Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Alembic Pharmaceuticals Limited cannot be verified against its exchange. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Alembic Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Alembic Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alembic Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Alembic Pharmaceuticals stock market strength indicators, traders can identify Alembic Pharmaceuticals Limited entry and exit signals to maximize returns
Alembic Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Alembic Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Alembic Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alembic to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0213 | |||
| Jensen Alpha | 0.0735 | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | (0.12) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Alembic Stock analysis
When running Alembic Pharmaceuticals' price analysis, check to measure Alembic Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alembic Pharmaceuticals is operating at the current time. Most of Alembic Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alembic Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alembic Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alembic Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets |